Storefront Science Competitors

CAS is a leader in scientific information solutions and a division of the American Chemical Society. For over 100 years, scientists, patent professionals, and business leaders have relied on CAS to provide the hindsight, insight, and foresight needed to accelerate breakthroughs and improve lives. Scientific data is growing at a nearly exponential rate. Finding the right information quickly, avoiding missed opportunities, and getting discoveries to market faster are constant pressures. CAS employs hundreds of scientists and technologists who curate, connect, and analyze the world's published science to reveal the unseen connections that drive confident decisions and fuel innovation. Our solutions support the full R&D and IP lifecycle: - CAS Newton℠: Agentic AI built for science, with conversational access to 150+ years of interconnected scientific knowledge - CAS SciFinder Discovery Platform™: Research and discovery tools that accelerate time to market - CAS BioFinder®: Integrated chemistry and biological data for drug discovery - STN IP Protection Suite™: Patent search and competitive intelligence - CAS IP Finder: AI-enhanced intellectual property search for teams at every level - CAS Custom Services℠: Tailored data curation and knowledge management solutions - CAS Intelligence Hub: Cloud-based, AI-ready scientific data at enterprise scale We serve biotechnology, life sciences, pharmaceutical, agrochemical, consumer goods, diversified chemicals, academia, law firms, patent offices, and independent research organizations. The success of AI and machine learning in science depends on data quality. CAS has the content, technology, and human expertise to help organizations build the data foundation they need to get real returns from their R&D investments. Connect with us at cas.org.

We're on a mission to spark human curiosity. Our four brands — Scribd®, Slideshare®, Everand™, and Fable — deliver knowledge, information, and inspiration to billions of people across the globe.

BenchSci’s vision is to exponentially increase the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence. Backed by F-Prime, Gradient Ventures (Google’s AI fund), Inovia Capital, and TCV, our platform accelerates science at 16 of the top-20 pharmaceutical companies, and over 4,300 leading research centers worldwide. We’re a remote-first company recognized for our impact and culture as a Deloitte Tech Fast 50TM, CIX Top 10 Growth, and Great Place to Work®.